EP 1744734 A2 20070124 - THERAPEUTIC COMBINATION COMPRISING A TISSUE FACTOR ANTAGONIST AND ANTI-CANCER COMPOUNDS
Title (en)
THERAPEUTIC COMBINATION COMPRISING A TISSUE FACTOR ANTAGONIST AND ANTI-CANCER COMPOUNDS
Title (de)
THERAPEUTISCHE KOMBINATION, ENTHALTEND EINEN GEWEBEFAKTORANTAGONISTEN UND ANTIKREBS-VERBINDUNGEN
Title (fr)
POLYTHERAPIE
Publication
Application
Priority
- DK 2005000098 W 20050214
- DK PA200400264 A 20040220
Abstract (en)
[origin: WO2005079766A2] The present invention relates to a novel pharmaceutical compositions comprising a combination of a compound, which binds to and inhibits the activity of tissue factor and a chemotherapeutic compound. The invention also relates to their use in the prophylaxis or treatment of diseases or disorders related to patho-physiological tissue factor (TF) functions.
IPC 8 full level
A61K 31/00 (2006.01); A61K 38/36 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); C07K 16/36 (2006.01)
CPC (source: EP)
A61K 31/00 (2013.01); A61K 38/36 (2013.01); A61K 39/395 (2013.01); A61K 45/06 (2013.01); A61P 1/04 (2017.12); A61P 5/20 (2017.12); A61P 7/00 (2017.12); A61P 7/02 (2017.12); A61P 9/00 (2017.12); A61P 9/02 (2017.12); A61P 9/10 (2017.12); A61P 11/00 (2017.12); A61P 11/02 (2017.12); A61P 11/06 (2017.12); A61P 11/08 (2017.12); A61P 19/00 (2017.12); A61P 19/02 (2017.12); A61P 19/06 (2017.12); A61P 19/08 (2017.12); A61P 29/00 (2017.12); A61P 31/04 (2017.12); A61P 35/00 (2017.12); A61P 35/02 (2017.12); A61P 37/06 (2017.12); A61P 37/08 (2017.12); Y02A 50/30 (2017.12)
C-Set (source: EP)
Citation (search report)
See references of WO 2005079766A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005079766 A2 20050901; WO 2005079766 A3 20051013; EP 1744734 A2 20070124; JP 2007523099 A 20070816
DOCDB simple family (application)
DK 2005000098 W 20050214; EP 05700648 A 20050214; JP 2006553435 A 20050214